Literature DB >> 22283650

Delivery methods of camptothecin and its hydrosoluble analogue irinotecan for treatment of colorectal cancer.

Adriano Mollica1, Azzurra Stefanucci, Federica Feliciani, Ivana Cacciatore, Catia Cornacchia, Francesco Pinnen.   

Abstract

Camptothecins are a family of alkaloids originally extracted from the Chinese tree Camptotheca acuminata, Nyssaceae, exhibiting a strong activity against colorectal cancer (CRC). CRC is a common malignancy worlwide. Despite significant developments in the treatment of this disease, it still causes considerable morbidity and mortality. Recent advances include both newer cytotoxic chemotherapies and novel biological agents including the more hydrosoluble camptothecin derivative, namely irinotecan. Camptothecin and irinotecan are selective human topoisomerase I inhibitors but their application for curing CRC is compromised by their intrinsic high toxicity, insolubility and instability. Furthermore, pharmacology studies have determined that continuously and prolonged schedules of administration are required. The aim of this work is to review the state of the art of camptothecin and its derivative irinotecan's delivery methods.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22283650     DOI: 10.2174/156720112800234558

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  7 in total

1.  Synthesis of water-soluble camptothecin-polyoxetane conjugates via click chemistry.

Authors:  Olga Yu Zolotarskaya; Alison F Wagner; Jason M Beckta; Kristoffer Valerie; Kenneth J Wynne; Hu Yang
Journal:  Mol Pharm       Date:  2012-10-23       Impact factor: 4.939

2.  Auraptene and its effects on the re-emergence of colon cancer stem cells.

Authors:  Francesco Epifano; Salvatore Genovese; Rebecca Miller; Adhip P N Majumdar
Journal:  Phytother Res       Date:  2012-07-04       Impact factor: 5.878

3.  Dual-Functional Polymeric Micelles Co-Loaded with Antineoplastic Drugs and Tyrosine Kinase Inhibitor for Combination Therapy in Colorectal Cancer.

Authors:  Ying-Hsia Shih; Cheng-Liang Peng; Ping-Fang Chiang; Ming-Jium Shieh
Journal:  Pharmaceutics       Date:  2022-03-31       Impact factor: 6.525

4.  Camptothecin inhibits the progression of NPC by regulating TGF-β-induced activation of the PI3K/AKT signaling pathway.

Authors:  Ben-Shan Li; Ji-Yi Huang; Jing Guan; Long-Hua Chen
Journal:  Oncol Lett       Date:  2018-05-10       Impact factor: 2.967

5.  Anticancer Activity of Saponins from Allium chinense against the B16 Melanoma and 4T1 Breast Carcinoma Cell.

Authors:  Zhihui Yu; Tong Zhang; Fengjuan Zhou; Xiuqing Xiao; Xuezhi Ding; Hao He; Jie Rang; Meifang Quan; Ting Wang; Mingxing Zuo; Liqiu Xia
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-03       Impact factor: 2.629

6.  Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.

Authors:  Samrat M Sanghvi; Jonathan W Lischalk; Ling Cai; Sean Collins; Mani Nair; Brain Collins; Keith Unger
Journal:  Radiat Oncol       Date:  2017-02-28       Impact factor: 3.481

Review 7.  Synthesis and bioactivity of secondary metabolites from marine sponges containing dibrominated indolic systems.

Authors:  Adriano Mollica; Marcello Locatelli; Azzurra Stefanucci; Francesco Pinnen
Journal:  Molecules       Date:  2012-05-21       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.